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In this issue of Cell Stem Cell, Rawlins et al. (2009) use an elegant lineage-tracing system to circumvent
technical obstacles that have long limited advances in lung stem cell research and, as a result, definitively
clarify the role of Clara cells in lung growth, homeostasis, and repair.
While endogenous tissue repair after lung
injury is well documented, developing
a therapeutic strategy for lung regenera-
tion or replacement in the wake of disease
remains far from being realized. Achieving
these goals is hampered by deficiencies in
our understanding of the basic signals
controlling lung tissue reconstitution and
particularly by the need to ascertain the
role and identities of stem and progenitor
cell populations that participate in this
process. In large part, this state of affairs
reflects the challenges imposed by the
lung’s complex biological properties,
including its intricate spatial configuration,
extensive cellular heterogeneity, and slow
cell turnover. Technical issues, including
a paucity of informative cellular markers
and regenerative experimental models,
have further hampered progress in the
field. Based on gene expression proper-
ties and in vitro differentiation potential,
several candidate lung stem cells,
including the so-called BASC cell (Kim
et al., 2005), have been isolated, but the
role of such cells in vivo remains uncertain.
In this issue of Cell Stem Cell, Rawlins
et al. (2009) use an elegant lineage-tracing
system that circumvents many of these
obstacles. Taking advantage of the
restricted expression of Scgb1a1 (also
known as CC-10), the authors generated
a ‘‘knockin’’ transgenic mouse with
a tamoxifen (TM) inducible Cre-recombi-
nase (ScgB1a1-CreER) that lineage-
tags Clara cells of the airway. By varying
the dose and timing of TM administration,
the authors provide new and detailed
information regarding the progenitor cell
properties, intrinsic turnover, and relative
contribution of Scgb1a1-expressing cells
to postnatal lung growth in homeostasis
and injury repair. Among their observa-
tions includedata showing that reconstitu-
tion of the epithelium in the bronchioles
involves Clara cell self-renewal and differ-
entiation into ciliated cells. Most notably,
the lineage-tracing studies reported in
this paper directly call into question
whether there is a role for so-called bron-
chioalveolar stem cells (BASC) in post-
natal lung growth and repair. While this
paper describes an effective strategy to
assay candidate airway stem cell popula-
tions, additional tools and approaches
will need to be developed to move the
lung stem field forward to a stage at which
regenerative therapies can be rationally
designed.
Challenges, Issues,
and New Approaches
The mammalian lung is an extraordinarily
intricate structure composed of at least
40 morphologically distinct mesodermal
and endodermal cell types. This organ
has three anatomically defined regions
composed of large airways (including
trachea), bronchioles, and alveoli, each
of which exhibit a morphologically distinct
epithelium. The three regions are arranged
to form a continuous, repeated series of
bifurcating epithelial tubes that terminate
in the vast alveolar gas exchange region.
These tubes are surrounded by differenti-
atedmesenchymal elements and supplied
by a dual vascular system. One important
tissue trait that is relevant to the search for
stem cell populations is that apart from
large airway regions, lung epithelial cells
in the extensive distal gas exchange
region turnover at a very slow rate (Bow-
den, 1983).
In part due to the lung’s intrinsic struc-
tural complexity and its relative quies-
cence, elucidation of cellular hierarchies
and identification of stem and progenitor
cells have been extremely challenging.
One way to overcome these issues is to
employ inducible lineage tracing strate-
gies that make use of powerful lung-cell-
specific promoters, such as the approach
used by Rawlins et al. (2009). Another
strategy involves taking advantage of the
fact that biological paradigms established
in more easily manipulated lower animals
can be used to elucidate rules that govern
the mammalian lung. One salient example
is the body of work on the rudimentary
Drosophila respiratory system (Ghabrial
et al., 2003). Many of the key signaling
pathways that control epithelial stem cell
growth and differentiation in this organism
havebeen found toplay fundamental roles
in mammalian lung development (Min
et al., 1998). While this approach may be
fruitful for developmental studies, para-
digms regulating repair and turnover in
the adult environment may be more diffi-
cult to study in lower animals, and the
mechanisms also may not be transferable
between species.
One key issue facing the mammalian
field with respect to designing models
and mechanisms of tissue repair is to
clarify the degree to which regionally
distinct mechanisms control tissue recon-
stitution ineachof the lung’s threeanatom-
ical regions. Developmental studies will
likely offer insights into this question, but
injury and replacement models in an adult
setting are also required. The findings in
the Rawlins paper, along with reports
from other groups (reviewed in Kotton
and Fine, 2008), support a model whereby
repair in each lung region is controlled
by separate and anatomically unique
patterns of tissue reconstitution. The valid-
ity of this concept rests, importantly, on
in vivo studies. For example, lineage
tracing demonstrated that Clara cells in
the trachea are replenished by a Scgb1a1
negative self-renewing precursor popula-
tion,whereasClaracells of the bronchioles
are replenished solely by a self-renewal
mechanism that does not involve a
Scgb1a1 negative precursor pool (Rawlins
et al., 2009). In contrast, the stem cell
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designation of the BASC, a cell type
defined by localization to the bronchioal-
veolar duct junction and by its coexpres-
sion of Clara cell (Scgb1a1) and alveolar
type II cell (SfpC) markers, was based
largely on in vitro studies (Kim et al.,
2005). While it is possible that the BASC
may contribute to lung cell turnover under
certain select conditions, such as cancer
(Dovey et al., 2008), the detailed in vivo
lineage tracing studies performedbyRaw-
lins et al. (2009) do not support a role for
this cell inmaintenance, growth, and repair
of bronchiolar and alveolar regions. The
findings of the Rawlins paper thus under-
score the importance and necessity of
in vivo strategies to clarify stemcell identity
andbiology.Additional toolswill have tobe
developed to address another important
issue raised by this work: whether there
are subpopulations of Clara cells that
possess distinctive stem and progenitor
cell properties and lineage potential.
While lineage tracing offers onemethod
to study candidate stem/progenitor cells
in vivo, advances in the lung field would
also be hastened by the development of
an experimental system in which putative
stem cells could be isolated and tested
for functional reconstitution following
delivery into an animal recipient. The value
of establishing experimental transplanta-
tion models is illustrated by the dramatic
advances achieved in the hematopoietic
stem cell field, which are largely attribut-
able to the fact that the entire blood
system can be reconstituted following
the transfer of a single stem cell. From
a historical perspective, it was fortuitous
that transplant conditioning and cell injec-
tion protocols were able to overcome
constraints that we now know control
hematopoietic stem cell engraftment,
including niche availability and targeted
homing. Overcoming similar constraints
in the emerging field of lung regeneration
is likely to be a daunting task. It is also
important to note that for a diffuse organ
like the blood, repair and regeneration
may not be dissimilar processes; in
contrast, repair and replacement of
a solid organ (like the lung) composed
of regionally and functionally distinct
parts are likely controlled by indepen-
dent mechanisms. One repercussion of
this concept is that efforts aimed to
harness endogenous cells for repair in
a diseased condition will likely involve
approaches that are quite different from
methods designed to regenerate an
entire lung. Although distinct regulatory
processes may be at work in each of
these two situations, lessons learned in
one venue will likely help inform the other
approach.
Indeed, an additional remaining basic
objective for the field is to resolve the
true capacity, extent, and mechanisms of
endogenous lung regeneration in the
adult. An important aspect of this complex
question involves clarifying the mecha-
nisms whereby precursor populations are
able to give rise to the appropriate mix of
progeny and become organized into
a spatially complex structure like the adult
lung. Though lung injury repair studies are
informative and highly relevant, these
systems do not address the fundamental
issue of whole-organ regeneration. This
distinction reflects the fact that injury
models often involve damage to a specific
cell type, as exemplified by Clara cell loss
after naphthalene, or involve spatially-
restricted damage to a discrete lung
region, as observed following hyperoxia-
induced alveolar injury. One approach
thatmay help address this important issue
is to intensely reevaluate older experi-
mental injury models, but with the aid of
state-of-the-art tools. For example, the
nature of the lung regrowth that is thought
to occur in humans and rodents after
removal of a single lung (so-called pneu-
monectomy) (Thurlbeck, 1983) is still rela-
tively undefined. The types of lineage
tracing tools developed by Rawlins et al.
(2009) would facilitate the study of lung
regeneration after pneumonectomy.
One additional implication of the work
performed by Rawlins et al. (2009) is that
classical hierarchical stem cell paradigms
of tissue reconstitutionmaynot necessarily
apply to the lung. Similar issues are being
addressed in other quiescent tissues such
as the pancreas and liver. In this regard,
stem cell-dependent and stem cell-inde-
pendent pathways for tissue regeneration
have already been identified in these two
organs; interestingly, the type of pathway
utilized is dependent on the nature of the
initial injury (Dor and Melton, 2008). As
with the other challenges facing lung biolo-
gists, shedding light on whether similar
mechanisms are at work in the lung and
dissecting the regulatory relationships
that control them will require the develop-
ment of a new generation of experimental
reagents and novel tissue reconstitution
systems.
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